The Tissium-sponsored clinical investigation of the ECLIPSIUM® System marks a key step in the development of innovative solutions for laparoscopic hernia repair. The upcoming study aims to assess its safety and performance in mesh fixation procedures, aligning with modern medical device regulatory requirements. It is set to commence, bringing important implications for clinical teams and regulatory professionals.
- What changed?
- Study details
- Device innovation highlights
- FAQ
- Conclusion
- Disclaimer
- Official study information
What changed?
The ECLIPSIUM® System, a new medical device for mesh fixation in hernia repairs, embarks on a clinical investigation led by Tissium. Scheduled for future recruitment, this study falls within the framework of regulatory efforts to ensure the safety and effectiveness of innovative surgical tools. Healthcare professionals operating in clinical, quality, and regulatory roles can anticipate new data directly relevant to laparoscopic repair procedures.
Study details
Current recruitment status
The investigation has not yet started recruiting participants. Further updates are expected as December 12, 2025 approaches, with full adherence to international clinical trial protocols.
Purpose of the study
This trial aims to evaluate both the safety and performance of the ECLIPSIUM® System and resorbable tacks (AbsorbaTack or SorbaFix). These devices are designed to enhance laparoscopic mesh fixation processes while meeting stringent regulatory compliance requirements.
Sponsorship
The clinical study is sponsored by Tissium, a company specializing in biomaterials and medical device innovations. Their involvement underscores a commitment to advancing surgical techniques and outcomes.
Device innovation highlights
Why the ECLIPSIUM® System?
The ECLIPSIUM® System represents a step forward in mesh fixation technology. It is engineered to simplify the laparoscopic procedure and reduce the complications associated with traditional tacking systems. The use of resorbable tacks also addresses concerns over long-term foreign objects in the body.
Regulatory significance
The study’s adherence to robust safety and performance evaluations positions the ECLIPSIUM® System and its auxiliary components as potential game-changers in hernia repair surgeries. Regulatory teams will closely follow as new data emerges.
FAQ
1. When does the study start recruiting?
Recruitment is expected in the future, but the study is currently marked as not yet recruiting.
2. Who sponsors the study?
Tissium sponsors this investigation, which focuses on advancing medical device solutions in laparoscopic surgery.
3. What devices are being tested?
The study involves the ECLIPSIUM® System for mesh fixation and resorbable tacks such as AbsorbaTack or SorbaFix.
Conclusion
This innovative study, led by Tissium, offers critical advancements in hernia repair technology. Its outcomes may reshape practices and regulatory frameworks for device approval processes in the medical field.
Disclaimer
This article is for informational purposes only and does not constitute legal or medical advice. Readers should consult appropriate professionals for detailed guidance.
Official study information
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07277946?term=medical+device